The Predictive Value of Elevated Neutrophil to Lymphocyte Ratio for Long-Term Cardiovascular Mortality in Peripheral Arterial Occlusive Disease

Journal of Cardiology - Japan
doi 10.1016/j.jjcc.2014.02.019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Predictive Value of Neutrophil-To-Lymphocyte Ratio in Diabetic Wound Healing

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2017English

Elevated Neutrophil-To-Lymphocyte Ratio in the Diagnosis of Hashimoto's Thyroiditis

Revista da Associacao Medica Brasileira
Medicine
2017English

Predictive Value of the Pretreatment Neutrophil-To-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma

Journal of Clinical Medicine
2018English

Pretreatment Neutrophil-To-Lymphocyte Ratio (NLR) and Platelet-To-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer

Asian Pacific Journal of Cancer Prevention
2019English

The Predictive Value of Platelet to Lymphocyte and Neutrophil to Lymphocyte Ratio in Determining Urethral Stricture After Transurethral Resection of Prostate

Turkish Journal of Urology
Urology
2017English

Predictive Value of Reactive Hyperemia for Cardiovascular Events in Patients With Peripheral Arterial Disease Undergoing Vascular Surgery

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2007English

Exploring the Prognostic Value of the Neutrophil-To-Lymphocyte Ratio in Cancer

Scientific Reports
Multidisciplinary
2019English

Association of Peripheral Arterial Disease With All-Cause Mortality, Cardiovascular Mortality and Cardiovascular Events

Angiology: Open Access
2013English

PC036. Elevated Neutrophil-Lymphocyte Ratio Predicts Mortality After Elective Endovascular Abdominal Aortic Aneurysm Repair

Journal of Vascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy